ArticlePloS one2021
Long durations from symptom onset to diagnosis and from diagnosis to treatment in obsessive-compulsive disorder: A retrospective self-report study.
Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.
- Prevalence of obsessive-compulsive disorder in the older person: a systematic review and meta-analysis.BMC geriatrics · 2024Pooled it
- Clinical Correlates of Poor Insight in Obsessive-Compulsive Disorder: An Integrative Cross-Sectional Analysis.Journal of clinical medicine · 2026Article
- Obsessive-Compulsive Training Experiences in United States (US) Medical School Education Programs.Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry · 2026Article
- Parents' Experiences of a Preventive Intervention for Children at Risk of Obsessive-Compulsive Disorder: A Qualitative Study.Child psychiatry and human development · 2026Article
- Prevention of Obsessive-Compulsive Disorder in At-Risk Children: A Feasibility Trial.Child psychiatry and human development · 2026Article
- Predictive validity of the Obsessive-Compulsive Inventory-4 and Florida Obsessive-Compulsive Inventory-II severity scale.Journal of psychiatric research · 2026Article
- Factors associated with delays in assessment and treatment of obsessive-compulsive disorder: A scoping review.Journal of obsessive-compulsive and related disorders · 2025Article
- Help-seeking behavior, treatment barriers and facilitators, attitudes and access to first-line treatment in German adults with obsessive-compulsive disorder.BMC psychiatry · 2025Article
- Article
- Australian Clinicians' Capabilities, Opportunities, and Motivations in Implementing Exposure and Response Prevention for Youth with Obsessive-Compulsive Disorder: An Exploratory Study.Children (Basel, Switzerland) · 2025Article
- Medication adherence in obsessive-compulsive disorders and evaluation of effective adherence support strategies.Frontiers in psychiatry · 2025Article
- Ketogenic Diet as a Nutritional Metabolic Intervention for Obsessive-Compulsive Disorder: A Narrative Review.Nutrients · 2024Review
- Article
- Stable through the COVID-19 pandemic: Results from a longitudinal telephone interview study in psychiatric outpatients.PloS one · 2022Article
- Sense of happiness and other aspects of quality of life in patients with obsessive-compulsive disorder.Frontiers in psychiatry · 2022Article
- Obsessive-Compulsive Disorder: A Medical School Curriculum and Textbook Review.Journal of medical education and curricular developmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough obsessive-compulsive disorder (OCD) is one of the most common mental disorders, it takes up to 17 years for patients with OCD to receive adequate therapy. According to existing outdated literature, this study aimed to investigate the current duration between symptom onset and diagnosis and between diagnosis and the beginning of therapy separately.
methodsIn a cross-sectional study, N = 100 patients diagnosed with OCD undergoing treatment in a psychiatric outpatient department were assessed, using self-report questionnaires on sociodemographic and clinical variables. Based on self-reported information, the durations between age at symptom onset and age at diagnosis, and between age at diagnosis and beginning of therapy were calculated. To investigate associated factors, two subgroups of patients, one with a short duration between symptom onset and diagnosis < 7 years, and another with a long duration between symptom onset and diagnosis ≥ 7 years, respectively, were compared. RESULTS AND
conclusionPatients reported first symptoms of OCD at a mean age of 18.72 years. The mean duration between age at symptom onset and age at diagnosis was 12.78 years and the mean duration between age at diagnosis and the beginning of therapy was 1.45 years. Subgroup comparison indicated that patients with a short duration between symptom onset and diagnosis were significantly younger than patients with a long duration. However, patients with a short duration between symptom onset and diagnosis were at an older age when they reported first symptoms of OCD. Further, they showed less severe symptoms of OCD, higher functioning levels, and less self-stigmatization than patients with a long duration. It can be concluded that the duration until patients with OCD are diagnosed correctly and receive adequate treatment is still very long. Therefore, the duration between symptom onset and diagnosis should be shortened. Further, the duration between diagnosis and the beginning of therapy could be a good additional approach to reduce the overall duration of untreated disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.